Viewray (VRAY) Earns Daily News Impact Score of 0.06
News headlines about Viewray (NASDAQ:VRAY) have trended somewhat positive on Saturday, Accern reports. The research firm rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Viewray earned a news sentiment score of 0.06 on Accern’s scale. Accern also assigned media stories about the company an impact score of 46.4599039587356 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Here are some of the news stories that may have impacted Accern Sentiment Analysis’s analysis:
- $14.34 Million in Sales Expected for Viewray Inc (VRAY) This Quarter (americanbankingnews.com)
- ViewRay: Buy The Secondary (seekingalpha.com)
- Analysts Anticipate Viewray Inc (VRAY) Will Announce Earnings of -$0.22 Per Share (americanbankingnews.com)
- Q3 2018 EPS Estimates for Viewray Inc Raised by B. Riley (VRAY) (americanbankingnews.com)
- Orbimed Advisors Llc Sells 521,607 Shares of Viewray Inc (VRAY) Stock (americanbankingnews.com)
VRAY has been the topic of several analyst reports. BidaskClub upgraded shares of Viewray from a “sell” rating to a “hold” rating in a report on Friday, July 6th. Cantor Fitzgerald restated a “buy” rating and issued a $13.00 price objective on shares of Viewray in a report on Friday, May 11th. ValuEngine upgraded shares of Viewray from a “sell” rating to a “hold” rating in a report on Wednesday, May 2nd. BTIG Research restated a “buy” rating and issued a $14.00 price objective on shares of Viewray in a report on Tuesday, August 7th. Finally, Mizuho restated a “buy” rating and issued a $13.00 price objective on shares of Viewray in a report on Monday, August 6th. One analyst has rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $12.58.
Viewray (NASDAQ:VRAY) last announced its quarterly earnings data on Friday, August 3rd. The company reported ($0.30) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.21) by ($0.09). Viewray had a negative net margin of 83.84% and a negative return on equity of 353.05%. The business had revenue of $16.44 million during the quarter, compared to analyst estimates of $15.97 million. During the same quarter in the prior year, the company earned ($0.15) earnings per share. The company’s quarterly revenue was up 2255.3% on a year-over-year basis. sell-side analysts expect that Viewray will post -0.76 EPS for the current fiscal year.
In other Viewray news, insider Fmr Llc sold 295,850 shares of the company’s stock in a transaction that occurred on Thursday, July 26th. The shares were sold at an average price of $12.08, for a total value of $3,573,868.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder Orbimed Advisors Llc sold 185,948 shares of the company’s stock in a transaction that occurred on Wednesday, August 15th. The shares were sold at an average price of $9.95, for a total transaction of $1,850,182.60. The disclosure for this sale can be found here. Insiders sold 3,436,496 shares of company stock valued at $36,326,958 in the last ninety days. Insiders own 43.93% of the company’s stock.
ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.
See Also: Asset Allocation and Your Retirement
Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.